Loading…
meRfi® Microbiome for Pharmacists: Structured, evidence-based access to gut microbiome literature organized by product, indication, and mechanism, and continuously updated across probiotics, prebiotics, synbiotics, FMT, and pharmacomicrobiomics.
Every entry links back to the primary literature with citations and study details, so you can move from a product to the underlying evidence in seconds at the counseling counter.
For pharmacists, meRfi® Microbiome delivers robust, strain-specific evidence and a clear separation of marketing claims from the evidence base — faster than manual PubMed searches and general-purpose AI tools. A free trial without a credit card makes it easy to see the difference in your daily counseling.
Pharmacies have a strong interest in probiotics and prebiotics as an OTC counseling area with high patient demand and economic relevance; FMT and the microbiome are perceived more as specialist background knowledge and a bridge to medical therapy. For many patients, pharmacies are the first point of contact for probiotics — e.g., during antibiotic therapy, diarrhea, irritable bowel symptoms, or questions about the immune system or "well-being." Many pharmacists frequently recommend probiotics, yet recognize knowledge gaps regarding mechanisms of action, strain-specific evidence, and clear indication boundaries.
What is needed is qualified, evidence-based counseling on:
• Benefits, risks, and interactions of pro- and prebiotics (e.g., with antibiotics or immunosuppressive drugs)
• Realistic expectation management regarding marketing claims
• Appropriate positioning of prebiotics within the context of diet, constipation, IBS, and metabolic risk factors
In light of the microbiome boom, demand for "gut flora products" and microbiome tests is growing. Pharmacies increasingly see their role in distinguishing credible from unreliable offers and in advising patients on indication-specific, dosed biotics strategies (product, duration, dose) while warning them against exaggerated promises and unnecessary microbiome tests.
The curated, continuously updated evidence base on the gut microbiota and related health topics provides the complete scientific context in a modern, encyclopedia-style format — including citations, study details, and structured summaries — and thus supports medication counseling, patient information, and drug safety.
The most popular manipulators of the intestinal microbiota are introduced.
More than 100 medical conditions are covered.
More than 50 medical conditions are covered.
It covers the reduction of adverse events of cancer therapy and the improvement of its efficacy.
The interaction between gut microbes and commonly used non-antibiotic drugs is complex and bidirectional.
The microbiome's ability to metabolize drugs opens up the potential to adjust the gut microbiome for enhanced treatment outcomes.
How defined bacterial consortia move from research to approved medicines.
... and more